[1]
B. Reguly, J. P. Jakupciak, and R. L. Parr, “3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores”, CUAJ, vol. 4, no. 5, pp. E118-E122, Apr. 2013.